The publisher has released its latest report: “United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on the analysis of the healthcare, regulatory and reimbursement landscape in UAE. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.
The United Arab Emirates (UAE) pharmaceutical industry has considerable development potential for international drugmakers, as the second-largest economy among Arab countries, after Saudi Arabia. The trend in market preferences toward generic drugs and other medical products may influence the future trajectory of the UAE pharmaceuticals sector, as enterprises increasingly attempt to produce generics to keep up with current market dynamics. In terms of US dollars, the pharmaceutical market increased from $2.9 billion in 2017 to $3.5 billion in 2020, at a compound annual growth rate (CAGR) of 7.0%. The market is expected to grow further at a CAGR of 7.2% from 2021 to $5.6 billion in 2027. The UAE is home to the regional headquarters and production sites of the majority of the world's leading global pharmaceutical businesses. In 2016, the medical devices market in the UAE was worth $1.3 billion, which increased at a CAGR of 12.7% to $2.4 billion in 2021. It is further expected to grow at a CAGR of 3.9% from 2022, reaching $2.9 billion in 2027. Sphere, an e-public health system for epidemiological monitoring and administration that was developed by the UAE's Ministry of Health and Prevention (MOHAP), was introduced during Dubai's Arab Health 2022 exhibition. It includes epidemiological analysis, detecting illness patterns and seasons, calculating critical indicators and utilizing them to make evidence-based choices, and developing epidemiological maps to address future hazards.
The United Arab Emirates (UAE) pharmaceutical industry has considerable development potential for international drugmakers, as the second-largest economy among Arab countries, after Saudi Arabia. The trend in market preferences toward generic drugs and other medical products may influence the future trajectory of the UAE pharmaceuticals sector, as enterprises increasingly attempt to produce generics to keep up with current market dynamics. In terms of US dollars, the pharmaceutical market increased from $2.9 billion in 2017 to $3.5 billion in 2020, at a compound annual growth rate (CAGR) of 7.0%. The market is expected to grow further at a CAGR of 7.2% from 2021 to $5.6 billion in 2027. The UAE is home to the regional headquarters and production sites of the majority of the world's leading global pharmaceutical businesses. In 2016, the medical devices market in the UAE was worth $1.3 billion, which increased at a CAGR of 12.7% to $2.4 billion in 2021. It is further expected to grow at a CAGR of 3.9% from 2022, reaching $2.9 billion in 2027. Sphere, an e-public health system for epidemiological monitoring and administration that was developed by the UAE's Ministry of Health and Prevention (MOHAP), was introduced during Dubai's Arab Health 2022 exhibition. It includes epidemiological analysis, detecting illness patterns and seasons, calculating critical indicators and utilizing them to make evidence-based choices, and developing epidemiological maps to address future hazards.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in UAE, and includes:
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Roche, Boehringer Ingehlheim, Merck, and Julphar
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, B Braun, Zimmer Biomet, Terumo, and Smith & Nephew
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UAE’s healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the UAE healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UAE healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1. Table of Contents1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts about the UAE Healthcare Market
2.3 Key Highlights: Healthcare Startups in UAE
2.4 Key Events: UAE Healthcare Industry, 2015-21
2.5 Key Events: UAE Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-22
2.7 Key Events: Top Completed Deals by Value, 2020-22
2.8 Country Profile, UAE, 2022
3. Overview of the Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, UAE
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, UAE
3.7 COVID-19 Epidemiology, UAE
3.8 COVID-19 Impact and Developments, UAE
3.9 COVID-19 Impact and Developments in the Healthcare Market, UAE
3.10 COVID-19 Clinical Trials Landscape, UAE
3.11 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, UAE, 2015-21
6.2 Deal Analysis: Medical Device Market, UAE, 2015-21
7. HealthTech Landscape
7.1 HealthTech Landscape, UAE
7.2 Digital Statistics, UAE
7.3 Adoption of Technology in Healthcare, UAE
7.4 HealthTech Deals Landscape, UAE
7.5 Key HealthTech Deals, UAE
7.6 Digital Regulations, UAE
7.7 HealthTech Landscape: Benefits and Risks, UAE
8. Market Access
8.1 Overview of Healthcare System, UAE
8.2 Overview of Insurance Providers, Public Insurance, UAE
8.3 Overview of Insurance Providers, Private Insurance, UAE
8.4 Reimbursement Process, UAE
8.5 Out-of-Pocket Spending and Healthcare Price Index, UAE
8.6 Pricing Policies, UAE
8.7 Market Access: Key Events Timeline, UAE, 2010-21
8.8 Regulatory Landscape, UAE
8.8.1 Overview of Regulatory Agencies, UAE
8.8.2 Marketing Authorization for Pharmaceutical Products, UAE
8.8.3 Marketing Authorization for Generic Medicines, UAE
8.8.4 Marketing Authorization for Biosimilars, UAE
8.8.5 Marketing Authorization for Pharmaceutical Products Derived from Natural Sources, UAE
8.8.6 Marketing Authorization for Medical Devices, UAE
8.8.7 Pharmaceutical Establishment Regulations, UAE
8.8.8 Pharmaceutical Export and Import Regulations, UAE
8.8.9 Medical Device Import Regulations, UAE
8.8.10 Intellectual Property Rights, Patent, UAE
8.8.11 Intellectual Property Rights, Trademark, UAE
8.8.12 Clinical Trial Regulation Process, UAE
8.8.13 Pharmaceutical Clinical Trials Landscape, UAE
8.8.14 Medical Device Clinical Trials Landscape, UAE
8.8.15 Pharmaceutical and Medical Device Advertising Regulations, UAE
8.8.16 Labeling and Packaging Regulations, UAE
9. Country Healthcare Landscape
9.1 UAE Healthcare Policy Highlights
9.2 Healthcare Facilities, UAE
9.3 Life Expectancy, UAE
9.4 Immunization Rate, UAE
9.5 Environmental Health, UAE
9.6 Healthcare Personnel, UAE
9.7 Disease Burden, UAE
9.8 Healthcare Expenditure, UAE
10 Trade Associations, UAE
11 Trade Fairs, UAE
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer
List of Tables
- Table 1: List of locally manufactured over-the-counter medicines, UAE, 2022
- Table 2: List of OTC-G medicines, UAE, 2022
- Table 3: List of OTC-P medicines, UAE, 2022
- Table 4: COVID-19 indicators (number), UAE and Global, 2022
- Table 5: Travel restrictions imposed during COVID-19, UAE, 2020-22
- Table 6: COVID-19 vaccine type and booster doses, UAE, 2022
- Table 7: Medical devices market, major segments ($M), UAE, 2021
- Table 8: Insurance Providers, UAE, 2021
- Table 9: Profit rates for drug pricing, UAE, 2021
- Table 10: Pharmaceutical pricing criteria, UAE, 2021
- Table 11: Pharmaceutical product service fees, UAE, 2022
- Table 12: Service fees for pharmaceutical products derived from natural sources , UAE, 2022
- Table 13: Medical device service fees, UAE, 2022
- Table 14: Pharmaceutical establishment service fees, UAE, 2022
- Table 15: Export service fees, UAE, 2022
- Table 16: Patent application fee, UAE, 2022
- Table 17: Advertisement service fees, UAE, 2019
- Table 18: Trade fairs, UAE, 2022
List of Figures
- Figure 1: Pharmaceutical market, revenue ($B), UAE, 2016-22
- Figure 2: Medical device market, revenue ($B), UAE, 2016-21
- Figure 3: Healthcare startups in UAE, 2022
- Figure 4: Country profile, UAE, 2022
- Figure 5: Pharmaceutical market, revenue ($B), UAE, 2016-21
- Figure 6: Pharmaceutical market, revenue forecast ($B), UAE, 2022-27
- Figure 7: Pharmaceutical exports ($M), UAE, 2014-20
- Figure 8: Top export partners, UAE, 2020
- Figure 9: Pharmaceutical imports ($B), UAE, 2014-20
- Figure 10: Top import partners, UAE, 2020
- Figure 11: Pharmaceutical distribution channels, UAE, 2021
- Figure 12: Tatmeen, a track-and-trace platform, UAE, 2021
- Figure 13: Major generic medicine manufacturers, UAE, 2021
- Figure 14: OTC medicines market, revenue ($M), UAE, 2014-21
- Figure 15: OTC medicines market, major distribution channels ($M), UAE, 2021
- Figure 16: OTC market by sub-categories of drugs, revenue ($M), UAE, 2021
- Figure 17: Major therapeutic areas, % (value), UAE, 2021
- Figure 18: Major therapeutic areas, % (volume), UAE, 2021
- Figure 19: COVID-19 (number of cases), UAE, 2020-22
- Figure 20: COVID-19 (number of deaths), UAE, 2020-22
- Figure 21: Stringency index, COVID-19, UAE, 2020-22
- Figure 22: Containment and health index, COVID-19, UAE, 2020-22
- Figure 23: COVID-19 Fiscal stimulus packages, UAE, 2020-21
- Figure 24: COVID-19 Vaccine doses administration, number of vaccine doses administered, UAE, 2022
- Figure 25: COVID-19 Vaccine booster doses administration, number of vaccine doses administered per 100 people, UAE, 2022
- Figure 26: Top COVID-19 markets by product categories (number of available marketed products), UAE, 2020-22
- Figure 27: Top COVID-19 products by equipment type (number of available marketed products), UAE, 2020-22
- Figure 28: Companies manufacturing COVID-19 NAATS and POC tests (number of available marketed products), UAE, 2020-22
- Figure 29: Top COVID-19 Nucleic acid amplification tests by equipment type (number of available marketed products), UAE, 2020-22
- Figure 30: COVID-19 clinical trial sponsors by trial count, UAE, 2020-22
- Figure 31: COVID-19 clinical trials count by phase, UAE, 2020-22
- Figure 32: COVID-19 clinical trials count by trial status, UAE, 2020-22
- Figure 33: Medical devices market, revenue ($B), UAE, 2016-21
- Figure 34: Medical devices market, revenue forecast ($B), UAE, 2022-27
- Figure 35: Medical devices market, major segments (%), UAE, 2021
- Figure 36: Hospital supplies market, revenue ($M), UAE, 2016-27
- Figure 37: Orthopedic devices market, revenue ($M), UAE, 2016-27
- Figure 38: General surgery market, revenue ($M), UAE, 2016-27
- Figure 39: Cardiovascular devices market, revenue ($M), UAE, 2016-27
- Figure 40: Neurology devices market, revenue ($M), UAE, 2016-27
- Figure 41: Diagnostics market, revenue ($M), UAE, 2016-21
- Figure 42: Diagnostics market, revenue forecast ($M), UAE, 2022-27
- Figure 43: Medical devices market, revenue ($B) of major companies, UAE, 2020
- Figure 44: Deal value and deal count, pharmaceutical market, UAE, 2015-21
- Figure 45: Deal value and deal count, quarterly, pharmaceutical market, UAE, 2015-21
- Figure 46: Deal value and deal count subtypes, pharmaceutical market, UAE, 2015-21
- Figure 47: Top therapy areas by deal value ($M), pharmaceutical market, UAE, 2015-21
- Figure 48: Top therapy areas by deal count, pharmaceutical market, UAE, 2015-21
- Figure 49: M&A deals bi-annually (by value and by number), pharmaceutical market, UAE, 2015-21
- Figure 50: Deal value and deal count, medical devices market, UAE, 2015-21
- Figure 51: Deal value and deal count, quarterly, medical devices market, UAE, 2015-21
- Figure 52: Deal value and deal count subtypes, medical devices market, UAE, 2015-21
- Figure 53: Top equipment sectors by deal value ($M), medical devices market, UAE, 2015-21
- Figure 54: Top equipment sectors by deal count, medical devices market, UAE, 2015-21
- Figure 55: Overview of DOH policy on digital health, UAE, 2020
- Figure 56: Deal value ($M) and deal count (number of deals), HealthTech, UAE, 2015-21
- Figure 57: Deal value ($M) and deal count (number of deals) by deal sub-category, HealthTech, UAE, 2015-21
- Figure 58: Overview of the priority areas of the DOH Policy on the Abu Dhabi Health Information Exchange, UAE, 2020
- Figure 59: Organizational structure of healthcare system, UAE, 2021
- Figure 60: Issue of a Health Card, UAE, 2021
- Figure 61: Drug formulary application requirements, UAE, 2021
- Figure 62: Pharmaceutical reimbursement process, UAE, 2021
- Figure 63: Out-of-pocket spending ($ per capita and % of health spending), UAE, 2014-21
- Figure 64: Annual inflation rate in health price index (% change accumulated in the year),UAE, 2015-21
- Figure 65: Distribution of out-of-pocket health expenditure (%), UAE, 2019
- Figure 66: Medicine pricing process, UAE, 2021
- Figure 67: Pharmaceutical product registration, UAE, 2022
- Figure 68: Biosimilar licensing procedure, UAE, 2019
- Figure 69: Requirements for registration of medicines derived from natural sources, UAE, 2022
- Figure 70: Required documents for registration of medical devices, UAE, 2022
- Figure 71: Medical device registration, UAE, 2022
- Figure 72: Requirements for pharmaceutical establishment registration, UAE, 2019
- Figure 73: Pharmaceutical establishment registration, UAE, 2019
- Figure 74: Export of medicines, UAE, 2019
- Figure 75: Required documents for import of medicines for personal use, UAE, 2022
- Figure 76: Procedure for obtaining an approval for import of medicines for personal use, UAE, 2022
- Figure 77: Required documents for import of medicines from a local agent, UAE, 2022
- Figure 78: Procedure for obtaining an approval for import of medicines from a local agent , UAE, 2022
- Figure 79: Documents required for the import of medical devices, UAE, 2022
- Figure 80: Procedure for obtaining an approval for import of medical devices, UAE, 2022
- Figure 81: Patent application process, UAE, 2022
- Figure 82: Trademark application process, UAE, 2022
- Figure 83: Regulatory process for interventional clinical trial approval, UAE, 2021
- Figure 84: Regulatory process for non-interventional clinical trial approval, UAE, 2021
- Figure 85: Pharmaceutical clinical trials count by trial status, UAE, 2020-22
- Figure 86: Pharmaceutical clinical trials count by phase, UAE, 2020-22
